Australia's most trusted
source of pharma news
Saturday, 20 April 2024
Posted 4 August 2022 PM
The Federal Government is acting quickly to limit the spread of the monkeypox virus (MPX) in Australia, securing 450,000 doses of Bavarian Nordic's yet-to-be TGA approved "new third-generation vaccine".
It's understood that Australia is one of a limited number of countries to secure supplies of this vaccine in 2022.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.